Elucidation of novel immune regulatory mechanism by PILR that belongs to NK cell receptor family.
Elucidation of novel immune regulatory mechanism by PILR that belongs to NK cell receptor family.
批准号:
18390151
负责人:
ARASE Hisashi
金额:
$10.77万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007
中文摘要
在本研究中,我们分析了NK细胞受体家族分子之一的PILR如何参与免疫系统。我们特别分析了PILR如何调节先天免疫反应和获得性免疫反应。此外,我们试图开发一种通过调节PILR和PILR配体之间的相互作用来调节过敏性疾病和自身免疫性疾病的方法。当我们分析了PILR配体的表达和配体的功能时,我们发现PILR识别CD8 T细胞上表达的CD45。此外,我们通过使用抗cd3单抗和PILR- ig融合蛋白刺激T细胞,分析了PILR与CD45相互作用的功能。从这些分析中,我们发现这种相互作用显著增强了CD8 T细胞的反应。此外,在抗原呈递细胞上表达的PILR显著增强了T细胞的应答。总之,我们发现PILR通过与CD8 T细胞上表达的CD45相互作用来调节CD8 T细胞的活化。调节CD45和PILR之间相互作用的方法的发展似乎涉及调节过敏性疾病和自身免疫性疾病的方法的发展。因此,进一步分析PILR的功能对阐明免疫调节机制具有重要意义。
英文摘要
In this study, we have analyzed how PILR, one of NK cell receptor family molecules, is involved in immune system. Especially, we have analyzed how PILR regulates innate immune response and acquired immune response. Furthermore, we have tried to develop a method to regulate allergic diseases and autoimmune diseases by regulating interaction between PILR and PILR ligands. When we have analyzed expression of PILR ligands and function of the ligands, we have found that PILR recognizes CD45 expressed on CD8 T cells. Furthermore, we analyzed the function of the interaction between PILR and CD45, by stimulating T cells with anti-CD3 mAb and PILR-Ig fusion protein. From these analyses, we found that the interaction significantly augment the response of CD8 T cells. Furthermore, PILR expressed on antigen presenting cells significantly augmented the response of T cells. In summary, PILR was revealed to regulate CD8 T cell activation by interacting with CD45 expressed on CD8 T cells. Development of methods to regulate interaction between CD45 and PILR seems to be involved in the development of methods to regulate allergic diseases and autoimmune diseases. Therefore, further analyses of the function of PILR seem to be important to elucidate the mechanism of immune regulation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Expression, crystallization and preliminary x-ray diffraction analysis of human paired Ig-like type 2 receptor α (PILR α)
人配对 Ig 样 2 型受体 α (PILR α) 的表达、结晶和初步 X 射线衍射分析
DOI:
--
发表时间:
2008
期刊:
J. Immunol. 64
影响因子:
--
作者:
[Tabata, S., Kuroki, K, Maita, N., Wang, J., Shiratori, I., Arase, H., Kohda, D., Maenaka, K]
通讯作者:
K
An essential role of sialylated O-linked sugar chains in the recognition of mouse CD99 by paired immunolobulin-like type 2 recefor (PILR)
唾液酸化 O 连接糖链在配对免疫球蛋白样 2 型接收器 (PILR) 识别小鼠 CD99 中的重要作用
DOI:
--
发表时间:
2008
期刊:
J. Immunol. 180
影响因子:
--
作者:
[Wang, J., Shiratori, I., Satoh, T., Lanier, L. L., Arase, H.]
通讯作者:
H.
Expression, crystallization and preliminary X-ray diffraction analysis of human paired Ig-like type 2 receptor alpha (PILRα).
人类配对 Ig 样 2 型受体 α (PILRα) 的表达、结晶和初步 X 射线衍射分析。
DOI:
--
发表时间:
2008
期刊:
Ada Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 64
影响因子:
--
作者:
[Tabata, S., Kuroki, K., Maita, N., Wang, J., Shiratori, I., Arase, H., Kohda, D., Maenaka, K.]
通讯作者:
K.
KIR3DS1, a Gene Implicated in Resistance to Progression to AIDS, Encodes a DAP12-Associated Receptor Expressed on NK Cells That Triggers NK Cell Activation.
KIR3DS1 是一种与抵抗 AIDS 进展有关的基因,编码在 NK 细胞上表达的 DAP12 相关受体,触发 NK 细胞激活。
DOI:
--
发表时间:
2007
期刊:
J. Immunol. 178・2
影响因子:
--
作者:
[Boyd RL, Takahama Y., Carr H.William]
通讯作者:
Carr H.William
「研究成果報告書概要(和文)」より
摘自《研究结果报告摘要(日文)》
DOI:
--
发表时间:
2005
期刊:
影响因子:
--
作者:
[Kawauchi, et. al., Nishimura et al., Dezawa et al., Yoshizawa et al., 星野 幹雄, 星野 幹雄]
通讯作者:
星野 幹雄
共 18 条
Mechanism of misfolded protein transportation to outside cells
-
批准号:25670143
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.5万
-
财政年份:2013
-
负责人:ARASE Hisashi
-
依托单位:
Analysis of function of misfolded proteins presented on MHC class II molecules.
-
批准号:24659223
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.5万
-
财政年份:2012
-
负责人:ARASE Hisashi
-
依托单位:
Mechanism of herpesvirus infection
-
批准号:23390112
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.65万
-
财政年份:2011
-
负责人:ARASE Hisashi
-
依托单位:
Study on immune evasion mechanism by Staphylococcus aureus via immune inhibitory receptors
-
批准号:23659223
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.58万
-
财政年份:2011
-
负责人:ARASE Hisashi
-
依托单位:
New immune regulatory mechanism by paired receptors
-
批准号:20390143
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.56万
-
财政年份:2008
-
负责人:ARASE Hisashi
-
依托单位:
Immune regulation by new NK receptor family molecules
-
批准号:16390141
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.54万
-
财政年份:2004
-
负责人:ARASE Hisashi
-
依托单位:
Mechanism of immune-surveillance and immune-regulation by paired receptors
-
批准号:16043210
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$25.34万
-
财政年份:2003
-
负责人:ARASE Hisashi
-
依托单位:
Analysis of signaling molecules for NK cell receptors
-
批准号:09670328
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:1997
-
负责人:ARASE Hisashi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
循环肿瘤细胞通过获得CD45逃避T细胞的抗肿瘤免疫及促进肿瘤转移的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:王雪萍
-
依托单位:
TGF-β降解TAL1在EPOR缺失导致荷瘤状态下CD45阳性红系前体细胞分化阻滞中的作用及机制
-
批准号:81972699
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:龙海霞
-
依托单位:
CD45 PTPs对脓毒症T细胞亚群分化调控机制及黄芪皂苷干预作用的研究
-
批准号:81960745
-
项目类别:地区科学基金项目
-
资助金额:34.0万元
-
批准年份:2019
-
负责人:万春平
-
依托单位:
反义非编码RNA调控淋巴细胞CD45亚型表达的研究
-
批准号:31870745
-
项目类别:面上项目
-
资助金额:59.0万元
-
批准年份:2018
-
负责人:苏中静
-
依托单位:
靶向CD45调节T细胞分化及自身免疫
-
批准号:2018JJ2351
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2018
-
负责人:练高建
-
依托单位:
骨髓单个核细胞中CXCR4(+)CD45(-)细胞群对慢性脑缺血的治疗作用及机制研究
-
批准号:81701162
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:李楠
-
依托单位:
黄芪皂苷调控CD45蛋白酪氨酸磷酸酯酶介导抗肿瘤免疫分子机制的研究
-
批准号:81460624
-
项目类别:地区科学基金项目
-
资助金额:50.0万元
-
批准年份:2014
-
负责人:万春平
-
依托单位:
CD45及剪接变构体在骨髓造血干细胞层面始动银屑病发病的机制研究
-
批准号:81171507
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:刘晓明
-
依托单位:
cd45途径NK细胞激活的细胞内信号传递研究
-
批准号:39770694
-
项目类别:面上项目
-
资助金额:12.0万元
-
批准年份:1997
-
负责人:沈锋
-
依托单位: